Clearstead Advisors’s SkinHealth Systems SKIN Stock Holding History

Clearstead Advisors’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20	Closed	-$28	–	2773
2025 Q4	$28	Buy	+20	New	+$29	﹤0.01%	2665

Other funds holding SKIN

CFM

Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Clearstead Advisors's SKIN Position: Q1 2026 in Review

Clearstead Advisors sold out of SkinHealth Systems (SKIN) in Q1 2026, closing a stake of 20 shares — an estimated $28 sold.

Clearstead Advisors first reported a position in SKIN in Q4 2025 and held it in 1 quarter. The position peaked at $28 in Q4 2025. 116 funds tracked by Wall St. Rank hold SKIN as of Q1 2026.

Clearstead Advisors reported no remaining SkinHealth Systems position as of Q1 2026 after selling out during the quarter.
Clearstead Advisors sold 20 SkinHealth Systems shares in Q1 2026, an estimated $28.
Clearstead Advisors first reported a position in SkinHealth Systems in Q4 2025 and held it in 1 quarter.
Clearstead Advisors's SkinHealth Systems position peaked at $28 in Q4 2025.
116 funds tracked by Wall St. Rank held SkinHealth Systems as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.